Patents by Inventor Fredrik H. Karlsson

Fredrik H. Karlsson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180179584
    Abstract: The present invention provides the use of metagenomics to identify a compositional or functional alteration of the gut metagenome related to atherosclerosis or atherosclerotic associated disease. Also provided are methods to identify a person having risk for atherosclerosis and associated diseases by determining the presence of specific bacterial groups or species and also metabolic functions in the person's gut microbiota and to use such information to develop a prevention or treatment strategy.
    Type: Application
    Filed: February 26, 2018
    Publication date: June 28, 2018
    Inventors: Fredrik Backhed, Fredrik H. Karlsson, Jens Nielsen
  • Patent number: 9881135
    Abstract: The present invention relates to the identification of a person having risk for developing type 2 diabetes (T2D) by determining the presence or absence of specific genes, gene clusters, genera or species of bacteria in the person's gastrointestinal microbiota. More specifically the invention relates to a model to identify an individual having or at risk of developing type 2 diabetes (T2D) using metagenomic clusters (MGCs), wherein said model is characterized by using different metagenomic clusters for different population groups. Also provided is the use of such a model in the identification of a person having risk for developing type 2 diabetes (T2D).
    Type: Grant
    Filed: December 13, 2013
    Date of Patent: January 30, 2018
    Assignee: METABOGEN AB
    Inventors: Fredrik Backhed, Fredrik H. Karlsson, Jens Nielson, Bjorn Fagerberg, Valentina Tremaroli
  • Publication number: 20150317444
    Abstract: The present invention relates to the identification of a person having risk for developing type 2 diabetes (T2D) by determining the presence or absence of specific genes, gene clusters, genera or species of bacteria in the person's gastrointestinal microbiota. More specifically the invention relates to a model to identify an individual having or at risk of developing type 2 diabetes (T2D) using metagenomic clusters (MGCs), wherein said model is characterised by using different metagenomic clusters for different population groups. Also provided is the use of such a model in the identification of a person having risk for developing type 2 diabetes (T2D).
    Type: Application
    Filed: December 13, 2013
    Publication date: November 5, 2015
    Inventors: Fredrik Backhed, Fredrik H. Karlsson, Jens Nielson, Bjorn Fagerberg, Valentina Tremarcoli
  • Publication number: 20150299776
    Abstract: The present invention provides the use of metagenomics to identify a compositional or functional alteration of the gut metagenome related to atherosclerosis or atherosclerotic associated disease. Also provided are methods to identify a person having risk for atherosclerosis and associated diseases by determining the presence of specific bacterial groups or species and also metabolic functions in the person's gut microbiota and to use such information to develop a prevention or treatment strategy.
    Type: Application
    Filed: October 3, 2013
    Publication date: October 22, 2015
    Inventors: Fredrik Backhed, Fredrik H. Karlsson, Jens Nielsen